hrp0089na2.1 | Cell engineering for treatment of diabetes | ESPE2018

Stem Cells as a Source of Beta Cells

Zulewski Henryk

The ultimate therapy for type 1 diabetes is the replacement of the lost insulin producing cells instead of the actual life-saving but imperfect substitution of insulin. The isolation of embryonic stem cells (ESC) and later the reprogramming of somatic cells into induced pluripotent stem cells (iPSC) raised enormous hopes for cell based therapies in diabetes type 1. The first important stage in the differentiation process of ESC/iPSC is the generation of definite endoderm that ...

hrp0082p3-d1-874 | Perinatal and Neonatal Endocrinology | ESPE2014

Clinical Characteristics and Phenotype–Genotype Analysis in Turkish Patients with Congenital Hyperinsulinism; Predominance of Recessive KATP Channel Mutations

Demirbilek Huseyin , Arya Ved Bhushan , Ozbek Mehmet Nuri , Akinci Aysehan , Dogan Murat , Demirel Fatma , Houghton Jayne , Kaba Sultan , Guzel Fatma , Baran Riza Taner , Unal Sema , Tekkes Selahattin , Flanagan Sarah E , Ellard Sian , Husssain Khalid

Background: Congenital hyperinsulinism (CHI) is the most common cause of hyperinsulinaemic hypoglycaemia in the neonatal, infancy, and childhood periods. Its clinical presentation, histology and underlying molecular biology are extremely heterogeneous.Objective and hypotheses: To describe the clinical characteristics, analyse the genotype–phenotype correlations and describe the treatment outcome of Turkish CHI patients.Method:...

hrp0089pl2 | Oxytocin and the healing power of love | ESPE2018

Oxytocin and the Healing Power of Love

Carter Sue

This presentation will discuss the hormonal and neural mechanisms that support the beneficial and healing effects of loving relationships. Love is deeply biological and has profound effects on our mental and physical health, pervading every aspect of our lives. Without loving relationships or in isolation, humans fail to flourish, even if all of their other basic needs are met. Two neuropeptides, oxytocin and the related molecule, vasopressin, and their receptors, form an inte...

hrp0095p1-562 | Pituitary, Neuroendocrinology and Puberty | ESPE2022

DNA methylation status of MKRN3 in puberty: studies in Central Precocious Puberty girls and in pubertal mouse

Fanis Pavlos , Morrou Maria , Tomazou Marios , Toumba Meropi , Neocleous Vassos , Skordis Nicos , A Phylactou Leonidas

Background: Makorin RING finger protein 3 (MKRN3) is an important factor located on chromosome 15 in the imprinting Prader-Willi syndrome - associated region. Imprinted MKRN3 expressed in hypothalamic regions essential for puberty initiation and mutations have been found in patients with central precocious puberty (CPP). CPP caused by the early activation of pulsatile Gonadotropin releasing hormone (GnRH) secretion is clinically defined by the early maturation...

hrp0097pl5 | Stem cells organoids and single cell transcriptomics | ESPE2023

Cracking the pituitary stem cell code across life using single-cell transcriptomics and organoid models

Vankelecom Hugo

The pituitary gland dynamically remodels during key timepoints of life to meet the prevailing endocrine demands of the organism. Mechanisms underlying this plasticity remain poorly understood. In particular, it is not clear how the pituitary stem cells are involved and biologically behave during pituitary remodeling processes. Indeed, pituitary stem cells remain highly enigmatic regarding cellular complexity, regulatory circuits, niche make-up and functional role. In our studi...

hrp0086p1-p598 | Growth P1 | ESPE2016

Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males

Mee Lee Sang , Cho Jung-Soo , Shin Chung Hye , Soo Park Min , Jae Park Soon

Background: ALT-P1 (CJ-40002) is a long-acting recombinant growth hormone (GH) fused with NexP, which is a long-acting carrier developed by Alteogen Inc. NexP is a protein engineered recombinant alpha1 antitrypsin with further increased in vivo half-life without a native proteinase inhibitor activity. In non-clinical studies of cynomologus monkeys, the extended half-life of hGH-NexP has been successfully proved without side effects in high dose as 20 mg per kg dose.<p clas...

hrp0097t14 | Section | ESPE2023

Circulating Progranulin in Human Infants: Relation to Prenatal Growth and Early Postnatal Nutrition

Díaz Marta , Mestres-Arenas Alberto , López-Bermejo Abel , de Zegher Francis , Villarroya Francesc , Ibáñez Lourdes

Background: Progranulin (PGRN) displays pleiotropic biological functions including on early embryogenesis, cell proliferation, lysosomal or neuronal functioning and wound repair, and has been proposed as a biomarker for metabolic diseases. Increased PGRN levels have been reported in type 2 diabetes, nonalcoholic fatty liver disease and in preeclampsia associated to placental dysfunction. However, the ontogeny of PGRN concentrations and the potential value of P...

hrp0097rfc10.1 | Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) &amp; Multisystem endocrine disorders | ESPE2023

A novel maternally inherited GNAS variant in a family with hyperphagia and obesity.

Purushothaman Preetha , Ramakrishnan Anand , Gevers Evelien

Introduction: Heterozygous inactivating mutations in the maternal allele of the GNAS gene typically result in pseudohypoparathyroidism (PHP), characterised by developmental delay, short stature, obesity, hormone resistance and bone abnormalities. GNAS variants were recently described in 1% of patients in the UK Genetics of Obesity cohort, resulting in reduced MC4R signalling. Here, we report another novel GNAS variant in a family wit...

hrp0092p3-125 | Fat, Metabolism and Obesity | ESPE2019

Fasting C-Peptide: A Useful Tool for Diagnosis of Type II Diabetes Mellitus in Overweight / Obese Adolescents Living in a Poor Resources Setting

Bodieu Chetcha Adele , Fomenky Njiandock Cecilia , Dehayem Mesmin , Sobngwi Eugene

Case Report: Two cases of type 2 diabetes mellitus (among which 1 case of metabolic syndrome) previously taken as type 1 diabetes mellitus in adolescents are presented and the evaluation and management are discussed. There was a family history of Diabetes mellitus in one of the adolescent. Both of them had signs of insulin resistance, they were overweight and obese respectively, poorly controlled on premix insulin. The laboratory test revealed a high HbA1C, dy...